TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $513M (100.0% shares, 0.0% debt)

Holdings (22)

IVERIC BIO INC 24.4%
Value $125M Shares 5,141,118 Est. Cost $17.57 Unrealized
COGT COGENT BIOSCIENCES INC 7.6%
Value $39.18M Shares 3,631,042 Est. Cost $8.48 Unrealized +50.9%
GERN GERON CORP 7.5%
Value $38.55M Shares 17,765,213 Est. Cost $1.57 Unrealized +80.8%
MDGL MADRIGAL PHARMACEUTICALS INC 7.1%
Value $36.32M Shares 149,917 Est. Cost $94.85 Unrealized +187.3%
TYRA TYRA BIOSCIENCES INC 6.2%
Value $31.96M Shares 1,989,103 Est. Cost $12.71 Unrealized -6.4%
VTYX VENTYX BIOSCIENCES, INC 5.3%
Value $27.33M Shares 815,724 Est. Cost $29.94 Unrealized +29.9%
KALV KALVISTA PHARMACEUTICALS, INC 5.2%
Value $26.69M Shares 3,395,495 Est. Cost $5.36 Unrealized +39.3%
CYMABAY THERAPEUTICS INC 5.2%
Value $26.58M Shares 3,048,257 Est. Cost $3.38 Unrealized
VECTIVBIO HOLDING AG 5.2%
Value $26.5M Shares 3,113,600 Est. Cost $8.63 Unrealized
AEROVATE THERAPEUTICS INC 4.3%
Value $21.81M Shares 1,081,274 Est. Cost $14.29 Unrealized
DYN DYNE THERAPEUTICS, INC 3.7%
Value $19.01M Shares 1,650,150 Est. Cost $12.99 Unrealized 0.0%
KURA KURA ONCOLOGY INC 3.4%
Value $17.41M Shares 1,423,642 Est. Cost $14.54 Unrealized -14.2%
VRDN VIRIDIAN THERAPEUTICS, INC 3.3%
Value $16.88M Shares 663,610 Est. Cost $18.63 Unrealized +72.1%
SLN SILENCE THERAPEUTICS PLC 2.5%
Value $13.05M Shares 2,104,875 Est. Cost $10.03 Unrealized
IMVT IMMUNOVANT, INC 2.0%
Value $10.16M Shares 654,853 Est. Cost $12.59 Unrealized +37.8%
TRDA ENTRADA THERAPEUTICS INC 1.7%
Value $8.482M Shares 584,955 Est. Cost $17.12 Unrealized
GPCR STRUCTURE THERAPEUTICS INC 1.6%
Value $8.326M Shares 350,000 Est. Cost $23.79 Unrealized
MERUS BV 1.1%
Value $5.52M Shares 300,000 Est. Cost $30.46 Unrealized
ACRS ACLARIS THERAPEUTICS INC 0.8%
Value $4.286M Shares 529,839 Est. Cost $15.07 Unrealized -15.8%
CABA CABALETTA BIO, INC 0.8%
Value $4.026M Shares 486,795 Est. Cost $3.64 Unrealized +157.1%
CCCC C4 THERAPEUTICS, INC. 0.8%
Value $3.925M Shares 1,250,000 Est. Cost $5.89 Unrealized 0.0%
ALPINE IMMUNE SCIENCES INC 0.4%
Value $1.954M Shares 253,069 Est. Cost $13.85 Unrealized